Results for tag: "Biktarvy"

Biktarvy is a combination drug used to treat HIV/AIDS. It is a single-tablet regimen that combines three antiretroviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Biktarvy is used to treat HIV-1 infection in adults and adolescents aged 12 years and older. It is also used to reduce the risk of HIV-1 infection in adults and adolescents who are at high risk of HIV-1 infection. Biktarvy works by blocking the action of the virus in the body, preventing it from multiplying and spreading. The Biktarvy market is a rapidly growing segment of the HIV/AIDS drugs market. It is a highly competitive market, with several companies offering their own versions of the drug. Companies in the Biktarvy market include Gilead Sciences, Mylan, and ViiV Healthcare. Show Less Read more